Trung Huynh
Stock Analyst at RBC Capital
(4.83)
# 454
Out of 4,668 analysts
313
Total ratings
77.1%
Success rate
23.4%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Downgraded: Hold | $142 → $150 | $148.99 | +0.68% | 22 | Aug 20, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,500 | $1,244.40 | +20.54% | 26 | Aug 5, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $64 | $65.47 | -2.25% | 23 | Aug 4, 2026 | |
| PFE Pfizer | Reiterated: Hold | $25 | $27.79 | -10.04% | 38 | Aug 4, 2026 | |
| ABBV AbbVie | Maintained: Buy | $280 | $261.83 | +6.94% | 12 | Jul 31, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $175 → $287 | $267.37 | +7.34% | 5 | Jul 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $595 → $660 | $826.64 | -20.16% | 10 | Nov 7, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $29 → $25 | $0.6912 | n/a | 4 | Aug 15, 2025 | |
| INSM Insmed | Maintained: Buy | $133 → $140 | $125.08 | n/a | 10 | Aug 13, 2025 | |
| AMGN Amgen | Maintained: Hold | $326 → $317 | $433.73 | n/a | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.2 → $1 | $1.99 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $38 | $39.94 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $3.19 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $8.13 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $3.19 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €10.00 → €13.50 | €10.00 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 700.00 → CHF 580.00 | CHF 585.80 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,600 | kr 2,141 | n/a | 5 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 350.00 | CHF 371.80 | n/a | 12 | Jul 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €44.00 → €40.00 | €53.00 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €14.00 → €12.00 | €10.40 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €105.00 | €163.40 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 670.00 | kr 296.15 | n/a | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €57.00 | €48.61 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 9,000p | 12,088p | n/a | 13 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $7.99 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 1,300p → 1,400p | 1,921p | n/a | 13 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €165.00 | €138.05 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €96.00 | €77.79 | n/a | 16 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 90.00 | CHF 126.34 | n/a | 10 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €35.00 | €78.96 | n/a | 1 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $73 | $46.14 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €83.00 | €215.93 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.46 | $33.41 | n/a | 2 | Jun 25, 2020 |
Merck & Co.
Aug 20, 2026
Downgraded: Hold
Price Target: $142 → $150
Current: $148.99
Upside: +0.68%
Eli Lilly and Company
Aug 5, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,244.40
Upside: +20.54%
Bristol-Myers Squibb Company
Aug 4, 2026
Maintained: Hold
Price Target: $64
Current: $65.47
Upside: -2.25%
Pfizer
Aug 4, 2026
Reiterated: Hold
Price Target: $25
Current: $27.79
Upside: -10.04%
AbbVie
Jul 31, 2026
Maintained: Buy
Price Target: $280
Current: $261.83
Upside: +6.94%
Johnson & Johnson
Jul 21, 2026
Maintained: Buy
Price Target: $175 → $287
Current: $267.37
Upside: +7.34%
Regeneron Pharmaceuticals
Nov 7, 2025
Maintained: Hold
Price Target: $595 → $660
Current: $826.64
Upside: -20.16%
Jasper Therapeutics
Aug 15, 2025
Maintained: Buy
Price Target: $29 → $25
Current: $0.6912
Upside: n/a
Insmed
Aug 13, 2025
Maintained: Buy
Price Target: $133 → $140
Current: $125.08
Upside: n/a
Amgen
Aug 6, 2025
Maintained: Hold
Price Target: $326 → $317
Current: $433.73
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: $1.2 → $1
Current: $1.99
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $44 → $38
Current: $39.94
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $10 → $7
Current: $3.19
Upside: n/a
Mar 29, 2025
Maintained: Buy
Price Target: $13 → $12
Current: $8.13
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4
Current: $3.19
Upside: n/a
Aug 24, 2023
Maintained: Hold
Price Target: €10.00 → €13.50
Current: €10.00
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 585.80
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,600
Current: kr 2,141
Upside: n/a
Jul 24, 2022
Maintained: Hold
Price Target: CHF 350.00
Current: CHF 371.80
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: €44.00 → €40.00
Current: €53.00
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: €14.00 → €12.00
Current: €10.40
Upside: n/a
Apr 13, 2022
Maintained: Hold
Price Target: €105.00
Current: €163.40
Upside: n/a
Apr 1, 2022
Maintained: Hold
Price Target: kr 670.00
Current: kr 296.15
Upside: n/a
Dec 13, 2021
Maintained: Hold
Price Target: €57.00
Current: €48.61
Upside: n/a
Nov 15, 2021
Maintained: Buy
Price Target: 9,000p
Current: 12,088p
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $29 → $31
Current: $7.99
Upside: n/a
Jun 22, 2021
Maintained: Sell
Price Target: 1,300p → 1,400p
Current: 1,921p
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: €165.00
Current: €138.05
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: €96.00
Current: €77.79
Upside: n/a
Apr 28, 2021
Maintained: Hold
Price Target: CHF 90.00
Current: CHF 126.34
Upside: n/a
Jan 20, 2021
Maintained: Sell
Price Target: €35.00
Current: €78.96
Upside: n/a
Oct 12, 2020
Maintained: Buy
Price Target: $56 → $73
Current: $46.14
Upside: n/a
Jul 28, 2020
Maintained: Hold
Price Target: €83.00
Current: €215.93
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.46
Current: $33.41
Upside: n/a